94 related articles for article (PubMed ID: 20399960)
21. Over expression of hypoxia-inducible protein 2, hypoxia-inducible factor-1alpha and nuclear factor kappaB is putatively involved in acquired renal cyst formation and subsequent tumor transformation in patients with end stage renal failure.
Konda R; Sugimura J; Sohma F; Katagiri T; Nakamura Y; Fujioka T
J Urol; 2008 Aug; 180(2):481-5. PubMed ID: 18550099
[TBL] [Abstract][Full Text] [Related]
22. Expression of the forkhead transcription factor FOXP1 is associated both with hypoxia inducible factors (HIFs) and the androgen receptor in prostate cancer but is not directly regulated by androgens or hypoxia.
Banham AH; Boddy J; Launchbury R; Han C; Turley H; Malone PR; Harris AL; Fox SB
Prostate; 2007 Jul; 67(10):1091-8. PubMed ID: 17477366
[TBL] [Abstract][Full Text] [Related]
23. Hypoxia-inducible factor is expressed in giant cell tumour of bone and mediates paracrine effects of hypoxia on monocyte-osteoclast differentiation via induction of VEGF.
Knowles HJ; Athanasou NA
J Pathol; 2008 May; 215(1):56-66. PubMed ID: 18283716
[TBL] [Abstract][Full Text] [Related]
24. Suppression of VEGF transcription in renal cell carcinoma cells by pyrrole-imidazole hairpin polyamides targeting the hypoxia responsive element.
Kageyama Y; Sugiyama H; Ayame H; Iwai A; Fujii Y; Huang LE; Kizaka-Kondoh S; Hiraoka M; Kihara K
Acta Oncol; 2006; 45(3):317-24. PubMed ID: 16644575
[TBL] [Abstract][Full Text] [Related]
25. Lipid peroxidation and renal cell carcinoma: further supportive evidence and new mechanistic insights.
Gago-Dominguez M; Castelao JE
Free Radic Biol Med; 2006 Feb; 40(4):721-33. PubMed ID: 16458203
[TBL] [Abstract][Full Text] [Related]
26. Epidemiology of renal cell cancer.
Cho E; Adami HO; Lindblad P
Hematol Oncol Clin North Am; 2011 Aug; 25(4):651-65. PubMed ID: 21763961
[TBL] [Abstract][Full Text] [Related]
27. Genetic syndromes associated with renal cell carcinoma: a review.
Azeem K; Kollarova H; Horakova D; Magnuskova S; Janout V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):231-8. PubMed ID: 22286808
[TBL] [Abstract][Full Text] [Related]
28. SnapShot: Renal Cell Carcinoma.
Ricketts CJ; Crooks DR; Sourbier C; Schmidt LS; Srinivasan R; Linehan WM
Cancer Cell; 2016 Apr; 29(4):610-610.e1. PubMed ID: 27070709
[TBL] [Abstract][Full Text] [Related]
29. The impact of obesity and adiponectin signaling in patients with renal cell carcinoma: A potential mechanism for the "obesity paradox".
Ito R; Narita S; Huang M; Nara T; Numakura K; Takayama K; Tsuruta H; Maeno A; Saito M; Inoue T; Tsuchiya N; Satoh S; Habuchi T
PLoS One; 2017; 12(2):e0171615. PubMed ID: 28178338
[TBL] [Abstract][Full Text] [Related]
30. Obesity, hypertension, and renal cancer.
Yu MC; Ross RK
N Engl J Med; 2001 Feb; 344(7):531-2. PubMed ID: 11221620
[No Abstract] [Full Text] [Related]
31. Molecular genetics of renal cell carcinoma.
Erlandsson R
Cancer Genet Cytogenet; 1998 Jul; 104(1):1-18. PubMed ID: 9648552
[TBL] [Abstract][Full Text] [Related]
32. Human renal cancer carcinogenesis: a review of recent advances.
Stadler W; Vogelzang NJ
Ann Oncol; 1993 Jun; 4(6):451-62. PubMed ID: 8394735
[No Abstract] [Full Text] [Related]
33. Inverse association of leptin levels with renal cell carcinoma: results from a case-control study.
Spyridopoulos TN; Petridou ET; Dessypris N; Terzidis A; Skalkidou A; Deliveliotis C; Chrousos GP;
Hormones (Athens); 2009; 8(1):39-46. PubMed ID: 19278051
[TBL] [Abstract][Full Text] [Related]
34. Obesity and renal cell carcinoma: Biological mechanisms and perspectives.
Venkatesh N; Martini A; McQuade JL; Msaouel P; Hahn AW
Semin Cancer Biol; 2023 Sep; 94():21-33. PubMed ID: 37286114
[TBL] [Abstract][Full Text] [Related]
35. Renal cell carcinoma (RCC): fatter is better? A review on the role of obesity in RCC.
Turco F; Tucci M; Di Stefano RF; Samuelly A; Bungaro M; Audisio M; Pisano C; Di Maio M; Scagliotti GV; Buttigliero C
Endocr Relat Cancer; 2021 Jun; 28(7):R207-R216. PubMed ID: 33949971
[TBL] [Abstract][Full Text] [Related]
36. HIF-2alpha: many cancers, one engine?
Franovic A; Lee S
Cell Cycle; 2010 Mar; 9(5):859-60. PubMed ID: 20348840
[No Abstract] [Full Text] [Related]
37. Metabolic syndrome and renal cell carcinoma.
Zhang GM; Zhu Y; Ye DW
World J Surg Oncol; 2014 Jul; 12():236. PubMed ID: 25069390
[TBL] [Abstract][Full Text] [Related]
38. Re: an investigation of risk factors for renal cell carcinoma by histologic subtype in two case-control studies.
Laguna MP
J Urol; 2014 Jan; 191(1):55. PubMed ID: 24331471
[No Abstract] [Full Text] [Related]
39. Familial Risk of Renal Cell Cancer and Interaction with Obesity and Hyperglycemia: A Population-Based Study.
Lee SW; Kim HJ; Kazmi SZ; Choi YJ; Hong G; Kim YS; Eom J; Swan H; Cha J; Kang T; Hann HJ; Ahn HS
J Urol; 2022 Aug; 208(2):251-258. PubMed ID: 35298291
[TBL] [Abstract][Full Text] [Related]
40. Fat and cholesterol regulator identified.
Hampton T
JAMA; 2006 Oct; 296(13):1579. PubMed ID: 17018797
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
